Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

33.10p
   
  • Change Today:
    -0.60p
  • 52 Week High: 71.80
  • 52 Week Low: 32.90
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 1,864,058
  • Market Cap: £178.87m
  • RiskGrade: 119

Alliance Pharma delays preliminary results

By Josh White

Date: Monday 22 Apr 2024

LONDON (ShareCast) - (Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday.
The AIM-traded firm said the results, initially scheduled for 23 April, would now be delayed until early May.

It said it expected to provide an update on the publication date by 26 April.

Following an earlier announcement on 5 April, Alliance Pharma informed shareholders that despite the advanced stage of the audit process, its auditor, Deloitte LLP, had requested more time to finalise their work.

"Alliance reiterates that the details provided in the full year trading update on 29 January remain accurate," the board said in its statement.

At 1414 BST, shares in Alliance Pharma were down 1.63% at 36.25p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 33.10p
Change Today -0.60p
% Change -1.78 %
52 Week High 71.80
52 Week Low 32.90
Volume 1,864,058
Shares Issued 540.40m
Market Cap £178.87m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.55% above the market average93.55% above the market average93.55% above the market average93.55% above the market average93.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
75.35% below the market average75.35% below the market average75.35% below the market average75.35% below the market average75.35% below the market average
12.73% below the sector average12.73% below the sector average12.73% below the sector average12.73% below the sector average12.73% below the sector average
Income
33.67% above the market average33.67% above the market average33.67% above the market average33.67% above the market average33.67% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
88.91% below the market average88.91% below the market average88.91% below the market average88.91% below the market average88.91% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 03-May-2024

Time Volume / Share Price
16:35 83,605 @ 33.10p
16:35 4,891 @ 33.10p
16:35 1,099 @ 33.10p
16:35 1,203 @ 33.10p
16:35 1,817 @ 33.10p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page